Table 1.
Summary of results with high to moderate certainty of evidence from umbrella review of systematic reviews with meta-analyses of randomised controlled trials on diet in the management of type 2 diabetes
| Outcomes | Type of dietary intervention | Effect estimates (mean difference, risk ratio, or risk difference (95% CI)) |
Certainty of evidence* |
| Changes within the clinically meaningful range | |||
| Body weight (kg) |
|
−2.37 (−3.30 to −1.44) | High ⨁⨁⨁⨁ |
|
−1.34 (−1.77 to −0.91) | Moderate ⨁⨁⨁〇 | |
| Body mass index |
|
−0.87 (−1.32 to −0.43) | High ⨁⨁⨁⨁ |
|
−1.13 (−1.88 to −0.38) | Moderate ⨁⨁⨁〇 | |
| Waist circumference (cm) |
|
−2.24 (−3.71 to −0.76) | Moderate ⨁⨁⨁〇 |
|
−2.41 (−3.50 to −1.32) | Moderate ⨁⨁⨁〇 | |
| Haemoglobin A1c (%) |
|
−0.47 (−0.60 to −0.34) | High ⨁⨁⨁⨁ |
| Fasting blood glucose (mmol/L) |
|
−0.63 (−0.99 to −0.27) | Moderate ⨁⨁⨁〇 |
|
−1.18 (−1.47 to −0.88) | Moderate ⨁⨁⨁〇 | |
|
−1.78 (−2.33 to −1.23) | Moderate ⨁⨁⨁〇 | |
| Fasting insulin (µIU/mL) |
|
−1.97 (−3.88 to −0.07) | Moderate ⨁⨁⨁〇 |
| HOMA-IR |
|
−0.82 (−1.38 to −0.25) | Moderate ⨁⨁⨁〇 |
|
−0.90 (−1.34 to −0.46) | Moderate ⨁⨁⨁〇 | |
|
−1.08 (−1.86 to −0.30) | Moderate ⨁⨁⨁〇 | |
| Triglycerides (mmol/L) |
|
−0.30 (−0.43 to −0.17) | High ⨁⨁⨁⨁ |
|
−0.41 (−0.72 to −0.10) | Moderate ⨁⨁⨁〇 | |
| Total cholesterol (mmol/L) |
|
−0.21 (−0.31 to −0.11) | Moderate ⨁⨁⨁〇 |
|
−0.19 (−0.33 to −0.05) | Moderate ⨁⨁⨁〇 | |
|
−0.24 (−0.31 to −0.16) | Moderate ⨁⨁⨁〇 | |
| Low density lipoprotein cholesterol (mmol/L) |
|
−0.10 (−0.18, -0.02) | Moderate ⨁⨁⨁〇 |
|
−0.23 (−0.37 to −0.09) | Moderate ⨁⨁⨁〇 | |
|
−0.18 (−0.31 to −0.05) | Moderate ⨁⨁⨁〇 | |
| High density lipoprotein cholesterol (mmol/L) |
|
0.06 (0.01 to 0.10) | Moderate ⨁⨁⨁〇 |
| Systolic blood pressure (mm Hg) |
|
−4.97 (−7.32 to −2.62) | Moderate ⨁⨁⨁〇 |
| Diastolic blood pressure (mm Hg) |
|
−1.98 (−3.05 to −0.91) | Moderate ⨁⨁⨁〇 |
| Reduced use of drug treatments |
|
Risk ratio 0.24 (0.12 to 0.35) | Moderate ⨁⨁⨁〇 |
| Changes not within the clinically meaningful range | |||
| Body weight (kg) |
|
−0.25 (−0.99 to 0.49) | Moderate ⨁⨁⨁〇 |
| Body mass index |
|
−0.36 (−0.53 to −0.20) | Moderate ⨁⨁⨁〇 |
| Haemoglobin A1c (%) |
|
−0.11 (−0.17 to −0.04) | High ⨁⨁⨁⨁ |
|
0.02 (−0.13 to 0.17) | Moderate ⨁⨁⨁〇 | |
| Fasting blood glucose (mmol/L) |
|
−0.03 (−0.17 to 0.12) | Moderate ⨁⨁⨁〇 |
| QUICKI |
|
0.02 (0.01 to 0.03) | Moderate ⨁⨁⨁〇 |
| Triglycerides (mmol/L) |
|
−0.12 (−0.22 to −0.01) | High ⨁⨁⨁⨁ |
|
−0.13 (−0.24 to −0.02) | Moderate ⨁⨁⨁〇 | |
| Low density lipoprotein cholesterol (mmol/L) |
|
0.02 (−0.10 to 0.14) | Moderate ⨁⨁⨁〇 |
|
−0.03 (−0.08 to 0.02) | Moderate ⨁⨁⨁〇 | |
|
−0.26 (−0.43 to −0.09) | Moderate ⨁⨁⨁〇 | |
| Non-high density lipoprotein cholesterol (mmol/L) |
|
−0.02 (−0.11 to 0.07) | Moderate ⨁⨁⨁〇 |
| High density lipoprotein cholesterol (mmol/L) |
|
−0.04 (−0.08 to −0.00) | Moderate ⨁⨁⨁〇 |
|
−0.02 (−0.07 to 0.03) | Moderate ⨁⨁⨁〇 | |
|
0.01 (−0.03 to 0.05) | Moderate ⨁⨁⨁〇 | |
| Systolic blood pressure (mm Hg) |
|
0.03 (−1.77 to 1.84) | Moderate ⨁⨁⨁〇 |
|
−0.11 (−1.10 to 0.88) | Moderate ⨁⨁⨁〇 | |
| Diastolic blood pressure (mm Hg) |
|
−0.21 (−1.21 to 0.79) | Moderate ⨁⨁⨁〇 |
| Blood urea nitrogen (mg/dL) |
|
−1.22 (−1.94 to −0.51) | Moderate ⨁⨁⨁〇 |
| C reactive protein (standardised mean difference) |
|
−0.87 (−1.11 to −0.63) | Moderate ⨁⨁⨁〇 |
| Major cardiovascular events |
|
Risk difference 0.94 (0.87 to 1.02) | High ⨁⨁⨁⨁ |
CI=confidence interval; HOMA-IR=homeostatic model assessment-insulin resistance; QUICKI=quantitative insulin sensitivity check index.
*Assessed with the GRADEpro tool.